Icalcaprant

N/A

Report date: 2026/02/25 20:02:36
NME

Base Information

Drug NameIcalcaprant
Drug Alias NameCVL-354ABBV-1354
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKappa opioid receptor antagonists
TargetsKappa opioid receptor
Therapy Area/IndicationsBipolar II DisorderBipolar I DisorderDepressive Disorder, Major +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesCerevel Therapeutics LlcAbbvie Inc
Inactive CompaniesPfizer Inc
Active IndicationsBipolar II DisorderBipolar I DisorderDepressive Disorder, Major +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksKEGG